413 results on '"Yang, Liu-Meng"'
Search Results
2. Discovery of ZFD-10 of a pyridazino[4,5-b]indol-4(5H)-one derivative as an anti-ZIKV agent and a ZIKV NS5 RdRp inhibitor
3. Antiviral effects of the fused tricyclic derivatives of indoline and imidazolidinone on ZIKV infection and RdRp activities of ZIKV and DENV
4. A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
5. Discovery of dehydroandrographolide derivatives with C19 hindered ether as potent anti-ZIKV agents with inhibitory activities to MTase of ZIKV NS5
6. The Deubiquitinase OTUD1 Influences HIV-1 Release by Regulating the Host Restriction Factor BST-2.
7. C6-structural optimizations of 2-aryl-1H-pyrazole-S-DABOs: From anti-HIV to anti-DENV activity
8. Cell membrane skeletal protein 4.1R participates in entry of Zika virus into cells
9. Non-volatile acylphloroglucinol components from Eucalyptus robusta inhibit Zika virus by impairing RdRp activity of NS5
10. Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs
11. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors
12. A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid
13. Modification of N-terminal α-amine of proteins via biomimetic ortho-quinone-mediated oxidation
14. Corrigendum to “Discovery of ZFD-10 of a pyridazino[4,5-b]indol-4(5H)-one derivative as an anti-ZIKV agent and a ZIKV NS5 RdRp inhibitor” [Antivir. Res. 214 (2023) 105607]
15. Discovery of novel 3-hydroxypicolinamides as selective inhibitors of HIV-1 integrase-LEDGF/p75 interaction
16. Rational design, synthesis, anti-HIV-1 RT and antimicrobial activity of novel 3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(piperazin-1-yl)propan-1-one derivatives
17. Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors
18. Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV‑1 Latency Reversing Agents.
19. C15-Imines of Natural Matrine Alkaloid as Anti-HIV-1 Agents
20. Synthesis and anti‐HIV activity of non‐nucleoside reverse‐transcriptase inhibitor DB02 phosphate derivatives based on water‐soluble optimization
21. Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75
22. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation
23. Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability
24. Identification of 6ω-cyclohexyl-2-(phenylamino carbonylmethylthio)pyrimidin-4(3H)-ones targeting the ZIKV NS5 RNA dependent RNA polymerase
25. Synthesis, structure–activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors
26. Anti-HIV activities of extracts from Pu-erh tea
27. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors
28. Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
29. Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity
30. Synthesis and biological evaluation of naphthyl phenyl ethers (NPEs) as novel nonnucleoside HIV-1 reverse transcriptase inhibitors
31. A Novel Enzyme-Linked Immunosorbent Assay for Screening HIV-1 Fusion Inhibitors Targeting HIV-1 Gp41 Core Structure
32. Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
33. A pair of new oxindole alkaloids isolated from Uncaria macrophylla.
34. Daphnane diterpenoids isolated from Trigonostemon thyrsoideum as HIV-1 antivirals
35. Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment
36. Novel Triazolopyridine-Based Bromodomain and Extra-Terminal Domain Inhibitors as Potent HIV Latency-Reversing Agents
37. Structure and bioactivity of triterpenoids from the stems of Schisandra sphenanthera
38. Kuguacins F–S, cucurbitane triterpenoids from Momordica charantia
39. A pair of new oxindole alkaloids isolated from Uncaria macrophylla
40. Dynamic Gravity Model and Dynamic Behavior Analysis Based on Improved Cost Function
41. Three new nortriterpenoids from Schisandra wilsoniana and their anti-HIV-1 activities
42. Recombinant protein of heptad-repeat HR212, a stable fusion inhibitor with potent anti-HIV action in vitro
43. Isolation and characterization of miscellaneous terpenoids of Schisandra chinensis
44. Compounds from Kadsura heteroclita and related anti-HIV activity
45. Anti-HIV-1 activity of lignans from the fruits of Schisandra rubriflora
46. A pair of new oxindole alkaloids isolated from Uncaria macrophylla
47. Flazinamide, a novel β-carboline compound with anti-HIV actions
48. Synthesis of New 2-(N-Arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones as HIV-1 Inhibitors In Vitro
49. Correction to “Rubriflordilactones A and B, Two Novel Bisnortriterpenoids from Schisandra rubriflora and Their Biological Activities”
50. Modification of N-Terminal α-Amine of Proteins via Biomimetic ortho-quinone-mediated Oxidation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.